4.5 Article

Effect of the guide strand 3′-end structure on the gene-silencing potency of asymmetric siRNA

Journal

BIOCHEMICAL JOURNAL
Volume 461, Issue -, Pages 427-434

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/BJ20140407

Keywords

asymmetric siRNA (asiRNA); human Argonaute2; RNA-induced silencing complex (RISC); RNAi; siRNA

Funding

  1. Global Research Laboratory grant from the Ministry of Education, Science, and Technology (MEST) of Korea [2008-00582]
  2. Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2059693]
  3. National Research Foundation of Korea (NRF) - Korean Government [MEST] [2012R1A2A2A01045528]
  4. Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ00820603, PJ00801101]
  5. National Research Foundation of Korea [2012R1A2A2A01045528, 2008-00582] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

siRNAs are short dsRNAs that mediate efficient target gene silencing in a sequence-specific manner. We previously developed a novel siRNA structure, called asiRNA (asymmetric siRNA), which alleviates the off-target effects associated with conventional siRNA structures without decreasing target gene silencing potency. In the present study, we explored the effect of the guide strand 3'-end structure on the gene silencing potency of asiRNA. Interestingly, asiRNAs with a 21 nt guide strand solely composed of RNA resulted in gene silencing that was more than 6-fold more efficient compared with the corresponding asiRNA guide strand harbouring a dTdT (deoxythymidine dinucleotide) at its 3'-end. We demonstrated that the molecular basis of potency of the asiRNA with a 21 nt guide strand composed solely of RNA was due to the enhanced formation of the RISC (RNA-induced silencing complex) and increased affinity towards hAgo2 (human Argonaute2). Our observations may assist researchers in designing new asiRNAs with high on-target silencing efficiency with low off-target effects, which is critical for applications in both basic research and therapeutic development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available